Duoneb and Osteoarthritis - a phase IV clinical study of FDA data

Summary:

Osteoarthritis is reported as a side effect among people who take Duoneb (albuterol sulfate; ipratropium bromide), especially for people who are female, 60+ old, also take Zometa, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Osteoarthritis when taking Duoneb. It is created by eHealthMe based on reports of 8,008 people who have side effects when taking Duoneb from the FDA, and is updated regularly.

What is Duoneb?

Duoneb has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 8,093 Duoneb users. Check the latest studies of Duoneb.

What is Osteoarthritis?

Osteoarthritis (a joint disease caused by cartilage loss in a joint) is found to be associated with 1,877 drugs and 2,645 conditions by eHealthMe. Check the latest studies of Osteoarthritis.

On Jul, 09, 2026

8,008 people reported to have side effects when taking Duoneb.
Among them, 96 people (1.2%) have Osteoarthritis.

Among these 96 people:

What is the gender of people who have Osteoarthritis when taking Duoneb? *

female: 67.71 %
male: 32.29 %

What is the age of people who have Osteoarthritis when taking Duoneb? *

What are other drugs people take besides Duoneb? *

What are other side effects people have besides Osteoarthritis? *

Pain: 74 people, 77.08%
Stress And Anxiety: 65 people, 67.71%
Atelectasis (partial or complete collapse of the lung): 54 people, 56.25%
Injury: 54 people, 56.25%
Osteonecrosis Of Jaw (death of bone of jaw): 52 people, 54.17%
Chest Pain: 51 people, 53.12%
Dyspnea (difficult or laboured breathing): 49 people, 51.04%
Osteoporosis (bones weak and more likely to break): 49 people, 51.04%
Joint Pain: 49 people, 51.04%
Fatigue (feeling of tiredness): 49 people, 51.04%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 13 people, 13.54%
Breast Cancer Metastatic: 13 people, 13.54%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 10.42%
Osteopenia (a condition where bone mineral density is lower than normal): 8 people, 8.33%
Pain: 8 people, 8.33%
Spondyloarthropathy (any joint disease of the vertebral column): 7 people, 7.29%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 6.25%
Metastases To Bone (cancer spreads to bone): 5 people, 5.21%
Insomnia (sleeplessness): 4 people, 4.17%
Light Chain Analysis Increased: 4 people, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Duoneb and have Osteoarthritis?

- Check whether Osteoarthritis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Duoneb:

Duoneb (8,093 reports)

Osteoarthritis treatments and more:

Osteoarthritis (95,654 reports)

How severe was Osteoarthritis and when was it recovered:

Osteoarthritis in Duoneb

Expand to all the drugs that have ingredients of albuterol sulfate; ipratropium bromide:

Osteoarthritis and drugs with ingredients of albuterol sulfate; ipratropium bromide (542 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Duoneb:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Osteoarthritis:

Osteoarthritis (1,877 drugs)

Browse all the conditions that are associated with Osteoarthritis:

Osteoarthritis (2,645 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate; ipratropium bromide (the active ingredients of Duoneb) and Duoneb (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.